0000929638-23-002767.txt : 20231012
0000929638-23-002767.hdr.sgml : 20231012
20231012193845
ACCESSION NUMBER: 0000929638-23-002767
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230929
FILED AS OF DATE: 20231012
DATE AS OF CHANGE: 20231012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GHALIE RICHARD G
CENTRAL INDEX KEY: 0001156208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41827
FILM NUMBER: 231323636
MAIL ADDRESS:
STREET 1: C/O FAVRILLE, INC
STREET 2: 10445 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-369-7100
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
form4.xml
X0508
4
2023-09-29
0001262104
MEI Pharma, Inc.
MEIP
0001156208
GHALIE RICHARD G
C/O MEI PHARMA, INC.
11455 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
true
Chief Medical Officer
false
Stock Option (Right to Buy)
7.01
2023-09-29
4
A
0
30000
0
A
2033-09-29
Common Stock
30000
30000
D
One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024.
/s/ David M. Urso, as attorney in fact
2023-10-12